<

 
Data updated 2025-05-08 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date99928769.1 (espacenet)  (Federated)  (European Patent Register), 19990617
Patent/reg. no. and dateDK/EP 1086076, 20041222
Publication date20010328
Priority no. and dateUS 90094 P, 19980619
EP pub. no. and date EP 1086076 20010328
Effective date
Applicant/ownerVERTEX PHARMACEUTICALS INCORPORATED, 50 Northern Avenue
Boston, MA 02210, US
Applicant ref. no.121821
InventorSHERRILL, Ronald George, Glaxo Wellcome Inc., Five Moore Drive, P.O. Box 13398
Research Triangle Park, NC 27709, US,
SPALTENSTEIN, Andrew, Glaxo Wellcome Inc., Five Moore Drive, P.O. Box 13398
Research Triangle Park, NC 27709, US,
FURFINE, Eric Steven, Glaxo Wellcome Inc., Five Moore Drive, P.O. Box 13398
Research Triangle Park, NC 27709, US,
ANDREWS, Clarence W., III, Glaxo Wellcome Inc., Five Moore Drive, P.O. Box 13398
Research Triangle Park, NC 27709, US,
LOWEN, Gregory, Thomas, P.O. Box 315
Williamsburg, VA 23187, US,
HALE, Michael, R., 42 Sunset Road
Bedford, MA 01730, US
RepresentativeBudde Schou A/S, Dronningens Tværgade 30, 1302 København K
Opponent
IPC ClassC07C 303/00
TitleSulfonamidinhibitorer af aspartylprotease
Int. application no.US1999013744
Int. publication no.WO1999065870
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact